Lynch & Associates Medtronic PLC Transaction History
Lynch & Associates
- $488 Million
- Q2 2025
A detailed history of Lynch & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Lynch & Associates holds 9,767 shares of MDT stock, worth $902,861. This represents 0.17% of its overall portfolio holdings.
Number of Shares
9,767
Previous 9,714
0.55%
Holding current value
$902,861
Previous $872,000
2.41%
% of portfolio
0.17%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding MDT
# of Institutions
2,437Shares Held
1.05BCall Options Held
10.3MPut Options Held
9.61M-
Vanguard Group Inc Valley Forge, PA125MShares$11.6 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.3 Billion0.2% of portfolio
-
State Street Corp Boston, MA60MShares$5.55 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.6MShares$3.84 Billion0.85% of portfolio
-
Jpmorgan Chase & CO New York, NY37.6MShares$3.48 Billion0.27% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $123B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...